Navigate Fool.com
Will ATRC beat
the market?

AtriCure, Inc. (NASDAQ: ATRC)

Community Rating: 2 Stars: Unattractive

16.97 1.06 (6.66%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.75
Previous Close $15.91
Daily Range $16.51 - $18.07
52-Week Range $8.48 - $23.00
Market Cap $465.1M
P/E Ratio -20.66
Dividend (Yield) $0.00 (0.0%)
Volume 436,930
Average Daily Volume 165,333
Current FY EPS -$0.83

How do you think ATRC
will perform against the market?

Top ATRC Bull/Bear Pitches


pennysplants (< 20)
Submitted June 29, 2010

Sometimes, you just take a small position in a long shot ... and ride it out. I think AtriCure may have turned the corner. Still a long shot ... but no longer a crap shoot.

1 Replies Reply Report this Post

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

Boston's Watchman Under New FDA Scrutiny

BSX's announcement of a third panel meeting for the Watchman device is a small setback, but a setback nonetheless.

Why AtriCure, Inc. Shares Surged

AtriCure updates its preliminary fourth-quarter and 2014 full-year guidance, but this is really what shareholders should be watching.

Healthcare Stocks Adding to Earlier Losses; AtriCure Jumps Nearly 12% After Q3 EPS, Revenue Beats

Sector Update: Healthcare

Why AtriCure Inc. Shares Jumped

Shares of AtriCure soar after it tops earnings expectations in the third-quarter. Can shares head even higher or are they now overvalued?

AtriCure to Announce Third Quarter 2013 Financial Results

In the Fight Against Atrial Fibrillation, AtriCure Launches Maze IV Training Program in Europe

Health Risks of Atrial Fibrillation Raised During Awareness Month

AtriCure Announces Commitment to Improve Lives of 250,000 Atrial Fibrillation Patients

AtriCure Appoints Scott Drake to Its Board of Directors

See More ATRC News...




Healthcare Information Services

AtriCure, Inc. (ATRC) Description

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. Website: http://www.atricure.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks